summary
Introduced
04/08/2024
04/08/2024
In Committee
04/29/2024
04/29/2024
Crossed Over
05/16/2024
05/16/2024
Passed
05/16/2024
05/16/2024
Dead
Signed/Enacted/Adopted
06/06/2024
06/06/2024
Introduced Session
2024 Regular Session
Bill Summary
CONCERNING REQUIRING THE COLORADO PRESCRIPTION DRUG AFFORDABILITY REVIEW BOARD TO CONSIDER INPUT FROM THE COLORADO RARE DISEASE ADVISORY COUNCIL UNDER CERTAIN CIRCUMSTANCES.
AI Summary
This bill requires the Colorado Prescription Drug Affordability Review Board to consider input from the Colorado Rare Disease Advisory Council when reviewing prescription drugs that have an approved orphan drug designation for one or more rare diseases and no other indications. The bill also allows the Rare Disease Advisory Council to offer input to the Prescription Drug Affordability Review Board on such drugs. The bill aims to ensure the Board takes into account the unique needs and perspectives of individuals with rare diseases when conducting affordability reviews of certain prescription drugs.
Committee Categories
Health and Social Services, Military Affairs and Security
Sponsors (33)
Shannon Bird (D)*,
Mary Bradfield (R)*,
Kyle Brown (D)*,
Joann Ginal (D)*,
Tony Hartsook (R)*,
Chris Kennedy (D)*,
Barbara Kirkmeyer (R)*,
Dafna Michaelson Jenet (D)*,
David Ortiz (D)*,
Rose Pugliese (R)*,
Jim Smallwood (R)*,
Perry Will (R)*,
Mary Young (D)*,
Rachel Zenzinger (D)*,
Andrew Boesenecker (D),
Janet Buckner (D),
Lisa Cutter (D),
Monica Duran (D),
Meg Froelich (D),
Eliza Hamrick (D),
Iman Jodeh (D),
Sheila Lieder (D),
Mandy Lindsay (D),
Meghan Lukens (D),
Paul Lundeen (R),
Bob Marshall (D),
Julie McCluskie (D),
Kyle Mullica (D),
Kevin Priola (D),
Cleave Simpson (R),
Marc Snyder (D),
Tammy Story (D),
Brianna Titone (D),
Last Action
Governor Signed (on 06/06/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...